Author:
Sliwa Thamer,Beham-Schmid Christine,Burgstaller Sonja,Buxhofer-Ausch Veronika,Gastl Günther,Geissler Klaus,Krauth Maria,Krippl Peter,Lang Alois,Petzer Andreas,Wöhrer Stefan,Wölfler Albert,Gisslinger Heinz
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Hasselbalch HC. The role of cytokines in the initiation and progression of myelofibrosis. Cytokine Growth Factor Rev. 2013;24(2):133–45. doi: 10.1016/j.cytogfr.2013.01.004 .
2. Gisslinger H, Jeryczynski G, Gisslinger B, Wolfler A, Burgstaller S, Buxhofer-Ausch V, et al. Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria. Leukemia. 2016;30(5):1126–32.
3. Thiele J, Kvasnicka HM, Mullauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710–8.
4. Barosi G. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter. Best Pract Res Clin Haematol. 2014;27(2):129–40.
5. Grießhammer M, Baerlocher G, Gisslinger H, Lengfelder E, Petrides PE. https://www.onkopedia.com/de/onkopedia/guidelines/primaere-myelofibrose-pmf/@@view/html/index.html . Accessed May 11, 2016.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献